OncoMD: Cancer Discovery Research at AACR Conference 2016

Home | Press | MedGenome to present on OncoMD, a genomics data analysis and interpretation platform, for cancer discovery research at the AACR Conference 2016

MedGenome to present on OncoMD, a genomics data analysis and interpretation platform, for cancer discovery research at the AACR Conference 2016

OncoMD Cancer Analytics Platform combines tumor mutation profiles, expression signatures, copy number variations, epigenetic alterations and drug sensitivity to create a holistic view of human cancer enabling discovery of new targets for therapy and prognosis.

Breast-Cancer-News-Today

Insurance-Industry-Today

Lung-cancer

OECD-NEWS-Today

Pharmaceutical-industry

Prostate-cancer

World-NEWS-Today

http://world.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-research

http://breastcancer.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-research

http://insurance.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-research

http://oecd.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-researchhttp://pharmaceuticals.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-research

http://prostatecancer.einnews.com/pr_news/318928618/medgenome-to-present-on-oncomd-a-genomics-data-analysis-and-interpretation-platform-for-cancer-discovery-research